Early effects of androgen deprivation on bone and mineral homeostasis: A prospective cohort study

Early effects of androgen deprivation on bone and mineral homeostasis: A prospective cohort study

Bibliographic Details
Main Authors:	Rougin Khalil, Leen Antonio, Michaël R. Laurent, Karel David, Na Ri Kim, Pieter Evenepoel, Anton Eisenhauer, Alexander Heuser, Etienne Cavalier, Sundeep Khosla, Frank Claessens, Dirk Vanderschueren, Brigitte Decallonne
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	Bone Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352187220301029

Similar Items

Androgens and estrogens in skeletal sexual dimorphism
by: Michaël Laurent, et al.
Published: (2014-04-01)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
by: Shtutman Michael, et al.
Published: (2010-04-01)

Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
by: Shimajiri Shohei, et al.
Published: (2011-05-01)

Androgen deprivation therapy and the risk of subsequent keratitis
by: Dai-Wei Liu, et al.
Published: (2021-01-01)

Lacrimal sac adenocarcinoma managed with androgen deprivation
by: David H. Abramson, et al.
Published: (2020-09-01)

A cost-outcome analysis of androgen deprivation therapy and androgen deprivation therapy combine radiotherapy for locally advanced prostate cancer
by: Wei-Na Wang, et al.
Published: (2011)

Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells.
by: Dominick G A Burton, et al.
Published: (2013-01-01)

CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer
by: Justin H. Hwang, et al.
Published: (2019-11-01)

Androgen deprivation modulates the inflammatory response induced by irradiation
by: Lin Paul-Yang, et al.
Published: (2009-03-01)

Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer
by: Giovanni Corona, et al.
Published: (2021-07-01)

Androgen deprivation therapy (castration therapy) and pedophilia: What’s new
by: Mauro Silvani, et al.
Published: (2015-09-01)

Relugolix – The novel oral androgen deprivation therapy for prostate cancer
by: Rahul Jena
Published: (2020-01-01)

Androgen deprivation therapy for prostate cancer and the risk of hematologic disorders.
by: Jui-Ming Liu, et al.
Published: (2020-01-01)

Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?
by: Piotr Zareba, et al.
Published: (2016-04-01)

Metabolomic effects of androgen deprivation therapy treatment for prostate cancer
by: Jen‐Tsan Chi, et al.
Published: (2020-06-01)

Transcription factors involved in prostate gland adaptation to androgen deprivation.
by: Rafaela Rosa-Ribeiro, et al.
Published: (2014-01-01)

Androgen deprivation therapy as backbone therapy in the management of prostate cancer
by: Merseburger AS, et al.
Published: (2016-11-01)

An Update on the Changing Indications for Androgen Deprivation Therapy for Prostate Cancer
by: Kristene Myklak, et al.
Published: (2011-01-01)

Antifracture agents for prostate cancer patients on androgen deprivation therapy
by: Bhupendra P Singh, et al.
Published: (2010-01-01)

Cardiovascular health in men on androgen deprivation therapy for prostate cancer
by: Gilbert, Stephen E.
Published: (2013)

Re: Final Report of the Intergroup Randomized Study of Combined AndrogenDeprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer
by: Malcolm D. Mason, et al.
Published: (2015-06-01)

Association Between Androgen Deprivation Therapy for Prostate Cancer and Alzheimer's Disease
by: Giannantoni-Ibelli, Gina
Published: (2018)

Influence of androgen deprivation therapy on glucose metabolism and ambulatory glucose profile
by: E. Yu. Grickevich, et al.
Published: (2021-05-01)

Androgen deprivation therapy and side effects: are GnRH antagonists safer?
by: Stephen J Freedland, et al.
Published: (2021-01-01)

Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
by: Uri Amit, et al.
Published: (2019-06-01)

Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer
by: Syed Imran Ali Shah
Published: (2015-01-01)

How do we define “castration” in men on androgen deprivation therapy?
by: Sarin Itty, et al.
Published: (2020-01-01)

Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation
by: Julia Lipianskaya, et al.
Published: (2014-08-01)

A Comprehensive Review of Androgen Deprivation Therapy and Immunotherapy on Prostate Cancer
by: ZHU Hui, et al.
Published: (2019-10-01)

Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes
by: Pietro Enea Lazzerini, et al.
Published: (2020-05-01)

Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
by: Nicoletta Ferrari, et al.
Published: (2017-12-01)

Androgen deprivation therapy promotes an obesity-like microenvironment in periprostatic fat
by: Stefano Mangiola, et al.
Published: (2019-05-01)

Effect of androgen deprivation therapy on cardiovascular risk factors in prostate cancer
by: Mahnaz Roayaei, et al.
Published: (2013-01-01)

Chlormadinone acetate is effective for hot flush during androgen deprivation therapy
by: Hidekazu Koike, et al.
Published: (2013-09-01)

The Response of Prostate Cancer to Androgen Deprivation and Irradiation Due to Immune Modulation
by: Chun-Te Wu, et al.
Published: (2018-12-01)

Androgen deprivation therapy and fracture risk in Chinese patients with prostate carcinoma.
by: Chi-Ho Lee, et al.
Published: (2017-01-01)

Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy
by: Matthew E. Johnson, et al.
Published: (2012-01-01)

Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots
by: Per-Anders Abrahamsson
Published: (2017-10-01)

Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
by: Røe Kathrine, et al.
Published: (2012-05-01)

Radiation therapy and androgen deprivation in the management of high risk prostate cancer
by: Alan Dal Pra, et al.
Published: (2011-04-01)